Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Haoqin Kanggan Granules
- Development stage
- Phase 2
- Lead developer
- Suzhou Youseen
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiao'er Haoqin Kanggan Granules is a Traditional Chinese Medicine (TCM) botanical formulation developed by Suzhou Yusen New Drug Development Co., Ltd. It is specifically designed for the treatment of acute upper respiratory tract infections in children, particularly those diagnosed with the "wind-heat with dampness" syndrome (风热夹湿证) according to TCM principles. The name suggests the inclusion of *Artemisia annua* (Hao) and *Scutellaria baicalensis* (Qin), which are traditionally used to clear heat and resolve dampness. The drug is currently undergoing clinical evaluation in China to establish its safety and efficacy profile in the pediatric population.
- Other names
- Xiao'er Haoqin Kanggan Keli小儿蒿芩抗感颗粒
02
Targets
IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Xiao'er Haoqin Kanggan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiao'er Haoqin Kanggan Granules.